Distinct cord blood C-peptide, adipokine, and lipidomic signatures by in utero HIV exposure

Pediatr Res. 2022 Jul;92(1):233-241. doi: 10.1038/s41390-021-01705-1. Epub 2021 Aug 26.

Abstract

Background: Early-life metabolic derangements in HIV-exposed uninfected (HEU) infants have been reported.

Methods: Pregnant women with HIV and HIV-uninfected pregnant women were enrolled with their newborns in a US cohort from 2011 to 2015. We measured cord insulin, C-peptide, and metabolic cytokines of HEU and HIV-unexposed uninfected (HUU) newborns using ELISA and metabolites, lipid subspecies, and eicosanoids via liquid chromatography/mass spectrometry. Linear regression was employed to assess the association of intrauterine HIV/ART with insulin and C-peptide. Graphical lasso regression was used to identify differences between metabolite/lipid subspecies networks associated with C-peptide.

Results: Of 118 infants, 56 were HEU, ART exposed. In adjusted analyses, mean cord insulin (β = 0.295, p = 0.03) and C-peptide (β = 0.522, p < 0.01) were significantly higher in HEU vs. HUU newborns. HEU neonates exhibited primarily positive associations between complex lipids and C-peptide, indicative of fuel storage, and augmented associations between cord eicosanoids and cytokines. HUU neonates exhibited negative associations with lipids and C-peptide indicative of increased fuel utilization.

Conclusion: Higher cord insulin and C-peptide in HEU vs. HUU newborns as well as differences in cord metabolites, metabolic-related cytokines, and eicosanoids may reflect a propensity for fuel storage and an inflammatory milieu suggestive of fetal metabolic changes associated with in utero HIV/ART exposure.

Impact: There is a paucity of studies assessing cord blood and neonatal metabolic health in HIV-exposed uninfected (HEU) newborns, an increasing population worldwide. Compared to HIV-unexposed uninfected (HUU) newborns, HEU newborns exhibit alterations in fuel homeostasis and an inflammatory milieu associated with in utero HIV/antiretroviral therapy (ART) exposure. The long-term implications of these neonatal findings are as yet unknown, but merit continued evaluation as this important and growing population ages into adulthood.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adipokines
  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • C-Peptide
  • Cytokines
  • Female
  • Fetal Blood
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Infant
  • Infant, Newborn
  • Lipidomics
  • Lipids
  • Pregnancy
  • Pregnancy Complications, Infectious*

Substances

  • Adipokines
  • Anti-Retroviral Agents
  • C-Peptide
  • Cytokines
  • Lipids